| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,726 | 14,904 | 3,727 | 965 | | Cost of Revenue | 3,961 | 10,282 | 3,072 | 1,235 | | | Gross Profit | 2,765 | 4,622 | 655 | (270) | | | Operating Expenses | | Research Development | 3,758 | 3,090 | 2,513 | 3,266 | | Selling General and Administrative | 7,910 | 7,434 | 6,771 | 7,126 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 595 | 589 | 478 | 498 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,498) | (6,491) | (9,107) | (11,160) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 59 | 67 | 222 | 346 | | Earnings Before Interest And Taxes | (9,439) | (6,424) | (8,885) | (10,814) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,439) | (6,424) | (8,885) | (10,814) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,439) | (6,424) | (8,885) | (10,814) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,439) | (6,424) | (8,885) | (10,814) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,439) | ($6,424) | ($8,885) | ($10,814) |
|
0.51% Nasdaq 
Income Statement
